Teva says Copaxone lawsuit will go to trial - BusinessWeek

Teva Pharmaceutical Industries Ltd. said Monday that its patent infringement lawsuit against companies that are trying to market a generic version of its multiple sclerosis drug Copaxone will go to trial. The U.S. District Court for the Southern District of New York declined a motion for summary judgment on the patents supporting Copaxone, Teva said. Copaxone is the company's best-selling branded product and the top MS drug in...